CoreWeave Faces Investor Pushback Over $9B Core Scientific Offer

CoreWeave CEO said the $9B proposed acquisition of Core Scientific is optional as investors push back. Shareholders and analysts argue the offer undervalues Core Scientific, with key investors urging rejection ahead of the October 30 vote.